关键信息
-
基因名
FLJ13798
- 应用
-
别名
FLJ13798; JmjC domain-containing protein 5; JMJD5; JMJD5 protein; jumonji domain containing 5; Jumonji domain-containing protein 5; KDM8_HUMAN; Lysine (K) specific demethylase 8; Lysine-specific demethylase 8
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N371
-
表达区间
1-416aa
-
氨基酸序列
MAGDTHCPAE PLAREGTLWE ALRALLPHSK EDLKLDLGEK VERSVVTLLQ RATELFYEGR RDECLQSSEV ILDYSWEKLN TGTWQDVDKD WRRVYAIGCL LKALCLCQAP EDANTVAAAL RVCDMGLLMG AAILGDILLK VAAILQTHLP GKRPARGSLP EQPCTKKARA DHGLIPDVKL EKTVPRLHRP SLQHFREQFL VPGRPVILKG VADHWPCMQK WSLEYIQEIA GCRTVPVEVG SRYTDEEWSQ TLMTVNEFIS KYIVNEPRDV GYLAQHQLFD QIPELKQDIS IPDYCSLGDG EEEEITINAW FGPQGTISPL HQDPQQNFLV QVMGRKYIRL YSPQESGALY PHDTHLLHNT SQVDVENPDL EKFPKFAKAP FLSCILSPGE ILFIPVKYWH YVRALDLSFS VSFWWS
-
分子量
47.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
FLJ13798 is a recombinant protein that has garnered interest in the field of molecular biology and biotechnology due to its potential implications in understanding various biological processes. Researchers have identified FLJ13798 as part of a family of proteins that may play crucial roles in cellular signaling pathways, immune response regulation, and tissue development. Initial studies indicate that this protein might be involved in processes such as cell proliferation and differentiation, making it a compelling target for further investigation. Moreover, the recombinant production of FLJ13798 enables scientists to study its structure and function in detail, shedding light on its interactions with other biomolecules. Given the rising prevalence of diseases linked to dysregulation of cellular mechanisms, understanding FLJ13798 may contribute to the development of novel therapeutic strategies. Moreover, the exploration of this protein could enhance our comprehension of certain pathological conditions, including cancer and autoimmune diseases, thereby opening avenues for targeted medical interventions. Researchers aim to delineate the specific roles of FLJ13798 in vivo and in vitro, facilitating its potential application in drug design and development. Overall, the ongoing research into FLJ13798 represents a vital step toward unraveling complex biological networks and discovering innovative solutions in health and disease management.
